Cor­rect­ed: Zevra CEO hits the ex­it as mi­nor­i­ty share­hold­er's nom­i­nees take board seats

Drug de­vel­op­er Zevra Ther­a­peu­tics, for­mer­ly known as Kem­Pharm, is con­tin­u­ing to make some changes to its lead­er­ship struc­ture.

On Mon­day, the Flori­da-based com­pa­ny an­nounced that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER